Updates in the Use of Biosimilars in the Management of Retinal Eye Disorders - Episode 2
Post-Market Surveillance of Biosimilars
Carl D. Regillo, MD, and Jennifer I. Lim, MD, review the regulatory oversight process regarding biosimilars after they have entered the market.
Latest News
Innovent announces first patient dosed in Phase 1 study of IBI324 in patients with diabetic macular edema
Rachitskaya: Archway found incidence of retinal fluid at Week 96 was generally comparable across treatment arms
Study: Changes in the retina may be linked to parts of the brain of healthy individuals at risk of Alzheimer’s